Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) are associated with poorer outcome after single mismatch unrelated donor stem cell transplantation: a study of the German Cooperative Transplant Study Group (GCTSG) within the German working group for bone marrow and blood stem cell transplantation (DAG-KBT)

被引：0
|
作者：
Ayuk, F. [1 ]
Bornhaeuser, M. [1 ]
Stelljes, M. [1 ]
Zabelina, T. [1 ]
Wagner, E-M [1 ]
Schmid, C. [1 ]
Christopeit, M. [1 ]
Kroeger, N. [1 ]
Bethge, W. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P364
引用
收藏
页码：S304 / S305
页数：2
相关论文
共 50 条
  • [41] Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions-A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group
    Schroeder, Thomas
    Rachlis, Elena
    Bug, Gesine
    Stelljes, Matthias
    Klein, Stefan
    Steckel, Nina Kristin
    Wolf, Dominik
    Ringhoffer, Mark
    Czibere, Akos
    Nachtkamp, Kathrin
    Dienst, Ariane
    Kondakci, Mustafa
    Stadler, Michael
    Platzbecker, Uwe
    Uharek, Lutz
    Luft, Thomas
    Fenk, Roland
    Germing, Ulrich
    Bornhaeuser, Martin
    Kroeger, Nicolaus
    Beelen, Dietrich W.
    Haas, Rainer
    Kobbe, Guido
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (04) : 653 - 660
  • [42] Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group
    N Basara
    H Baurmann
    K Kolbe
    A Yaman
    M Labopin
    A Burchardt
    C Huber
    A A Fauser
    R Schwerdtfeger
    Bone Marrow Transplantation, 2005, 35 : 1011 - 1018
  • [43] Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
    Esther Schuler
    Eva-Maria Wagner-Drouet
    Salem Ajib
    Gesine Bug
    Martina Crysandt
    Sabine Dressler
    Andreas Hausmann
    Daniela Heidenreich
    Klaus Hirschbühl
    Matthias Hoepting
    Edgar Jost
    Jennifer Kaivers
    Stefan Klein
    Michael Koldehoff
    Lambros Kordelas
    Oliver Kriege
    Lutz P. Müller
    Christina Rautenberg
    Judith Schaffrath
    Christoph Schmid
    Daniel Wolff
    Rainer Haas
    Martin Bornhäuser
    Thomas Schroeder
    Guido Kobbe
    Annals of Hematology, 2021, 100 : 2141 - 2142
  • [44] Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
    Schuler, Esther
    Wagner-Drouet, Eva-Maria
    Ajib, Salem
    Bug, Gesine
    Crysandt, Martina
    Dressler, Sabine
    Hausmann, Andreas
    Heidenreich, Daniela
    Hirschbuehl, Klaus
    Hoepting, Matthias
    Jost, Edgar
    Kaivers, Jennifer
    Klein, Stefan
    Koldehoff, Michael
    Kordelas, Lambros
    Kriege, Oliver
    Mueller, Lutz P.
    Rautenberg, Christina
    Schaffrath, Judith
    Schmid, Christoph
    Wolff, Daniel
    Haas, Rainer
    Bornhaeuser, Martin
    Schroeder, Thomas
    Kobbe, Guido
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 959 - 968
  • [45] Reduced-intensity conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation : a study by the European Group for Blood and Marrow Transplantation Chronic Malignancies Working Party
    Auner, H. W.
    Szydlo, R.
    van Biezen, A.
    Iacobelli, S.
    Gahrton, G.
    Milpled, N.
    Volin, L.
    Janssen, J.
    Quoc, S. Nguyen
    Michallet, M.
    Schoemans, H.
    El Cheikh, J.
    Petersen, E.
    Guilhot, F.
    Schoenland, S.
    Ahlberg, L.
    Morris, C.
    Garderet, L.
    de Witte, T.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S17 - S17
  • [46] Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group
    Basara, N
    Baurmann, H
    Kolbe, K
    Yaman, A
    Labopin, M
    Burchardt, A
    Huber, C
    Fauser, AA
    Schwerdtfeger, R
    BONE MARROW TRANSPLANTATION, 2005, 35 (10) : 1011 - 1018
  • [47] Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    Kroeger, Nicolaus
    Holler, Ernst
    Kobbe, Guido
    Bornhaeuser, Martin
    Schwerdtfeger, Rainer
    Baurmann, Herrad
    Nagler, Arnon
    Bethge, Wolfgang
    Stelljes, Matthias
    Uharek, Lutz
    Wandt, Hannes
    Burchert, Andreas
    Corradini, Paolo
    Schubert, Joerg
    Kaufmann, Martin
    Dreger, Peter
    Wulf, Gerald G.
    Einsele, Hermann
    Zabelina, Tatjana
    Kvasnicka, Hans Michael
    Thiele, Juergen
    Brand, Ronald
    Zander, Axel R.
    Niederwieser, Dietger
    de Witte, Theo M.
    BLOOD, 2009, 114 (26) : 5264 - 5270
  • [48] Reactivation of toxoplasmosis infection after allogeneic hematopoietic stem cell transplantation (HSCT). A prospective study by the European group for blood and marrow transplantation (EBMT) infectious diseases working party (IDWP).
    Martino, R
    Bretagne, S
    Einsele, H
    Ullmann, A
    Maertens, J
    Parody, R
    Cordonnier, C
    BLOOD, 2003, 102 (11) : 197A - 197A
  • [49] Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)
    Kuchenbauer, Florian
    Bunjes, Donald W.
    Herr, Wolfgang
    Heuser, Michael
    Spaeth, Daniela
    Casper, Jochen
    Horst, Heinz August
    Brossart, Peter
    Held, Gerhard
    Kobbe, Guido
    Ringhoffer, Mark
    Wattad, Mohammed
    Salih, Helmut R.
    Goetze, Katharina
    Wulf, Gerald
    Theobald, Matthias
    Rummel, Mathias J.
    Fiedler, Walter
    Westermann, Joerg
    Salwender, Hans
    Petzer, Andreas L.
    Hartmann, Frank
    Luebbert, Michael
    Martens, Uwe
    Greil, Richard
    Kirchner, Hartmut H.
    Paschka, Peter
    Gaidzik, Verena I.
    Teleanu, Veronica
    Thol, Felicitas
    Goehring, Gudrun
    Doehner, Konstanze
    Ganser', Arnold
    Doehner, Hartmut
    Schlenk, Richard F.
    BLOOD, 2014, 124 (21)
  • [50] Allogeneic Stem Cell Transplantation after Conditioning with Treosulfan, Etoposide and Cyclophosphamide for Patients with Acute Lymphoblastic Leukemia (ALL) Not Eligible for TBI-Containing Regimens: A Phase II-Study on Behalf of the German ALL Study Group (GMALL) and the German Cooperative Transplant Study Group
    Kroeger, Nicolaus
    Bornhaeuser, Martin
    Stelljes, Matthias
    Pichlmeier, Uwe
    Schmid, Christoph
    Arnold, Renate
    Bug, Gesine
    Meyer, Ralf Georg
    Bethge, Wolfgang A.
    Kobbe, Guido
    Beelen, Dietrich
    BLOOD, 2014, 124 (21)
12345